NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

INVO Fertility, Inc. (IVF) Stock Analysis

INVO Fertility, Inc. (IVF) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

IVF

$0.99

+$0.00 (+0.20%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IVF with… →

IVF Key Statistics

As of Sep 4, 2026
Trading
Open
$0.98
Previous Close
$0.98
Day's Range
0.97–0.99
52-Week Range
0.90–84.40
Volume
187.00K
Valuation
Market Cap
$2.47M
P/E Ratio
0.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.33
EPS (ttm)Profit attributable to each share over the last twelve months.
357.88
Financials (FY)
Revenue (FY)
$6.84M+4.73%
Net Income (FY)
−$23.32M
Profit marginThe share of revenue left as profit after all costs and taxes.
−70.18%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.51M
1-Year Return
−97.08%
Dividend and dates
Avg Volume
4.24M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

IVF Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−73.84%
2025−99.68%
2024−40.00%
2023−84.08%
2022−87.27%
2021+10.63%
2020 (partial year)−79.90%

As of September 4, 2026.

IVF Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$6.84M−$23.32M−340.9%
2024$6.53M−$9.26M−141.7%
2023$3.02M−$8.03M−266.0%
2022$822.20K−$10.89M−1324.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$6.84M$2.53M−$5.84M−$23.32M−340.9%
2024$6.53M$2.87M−$6.12M−$9.26M−141.7%
2023$3.02M$1.09M−$6.77M−$8.03M−266.0%
2022$822.20K−$28.57K−$10.63M−$10.89M−1324.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

IVF Valuation vs Medical Devices Median

Median of 151 stocks
MetricIVFMedical Devices medianvs median
P/E0.0026.800.0x the median
P/S ratio0.332.980.1x the median
Profit margin−70.18%−1.69%68.5 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

INVO Fertility, Inc. (IVF) is capitalised at $2.47M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 40.

Over the past 52 weeks the price has ranged from $0.90 to $84.40. The most recent close on file for IVF is $0.99, dated September 4, 2026. That is $0.00 (+0.20%) against the previous close. The latest close sits 9.44% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $6.84M. Against the prior fiscal year total of $6.53M, that is a change of +4.73%. The same year closed with a net loss of $23.32M. Profit margin runs at −70.18%. That is 68.5 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are 357.88.

Across the 4 fiscal years on file, revenue moves from $822.20K in 2022 to $6.84M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

IVF trades at a trailing price-to-earnings ratio of 0. Measured against sales, the shares trade at 0.33 times revenue. On price-to-sales that is 0.1 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −97.08%. Measured over 5 years, that is −90.24% a year compounded. Daily returns over the trailing 5 years annualize to a volatility of 225.35%.

Growth & Income

No dividend is on file for IVF.

Across the complete calendar years on file, 2021 returned +10.63% and 2025 returned −99.68%. Of the 5 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −73.84% year to date.

Peer Comparison

INVO Fertility, Inc. (IVF) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
INVO Fertility, Inc. IVF $2.47M 0.0
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. INVO Fertility, Inc. trades at a P/E of 0.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About INVO Fertility, Inc.

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Visit website →